β2-Adrenergic receptor agonist ameliorates phenotypes and corrects microRNA-mediated IGF1 deficits in a mouse model of Rett syndrome
about
Insulin-like growth factors and their potential role in cardiac epigeneticsDevelopmental Dynamics of Rett SyndromeGenes, circuits, and precision therapies for autism and related neurodevelopmental disordersMeCP2 Affects Skeletal Muscle Growth and Morphology through Non Cell-Autonomous MechanismsAdvancing the understanding of autism disease mechanisms through geneticsLoss of MeCP2 in cholinergic neurons causes part of RTT-like phenotypes via α7 receptor in hippocampusPrenatal exposure to valproic acid increases miR-132 levels in the mouse embryonic brainFunctional recovery with recombinant human IGF1 treatment in a mouse model of Rett Syndrome.Regulation of IGF -1 signaling by microRNAs.Cognition and mood-related behaviors in L3mbtl1 null mutant mice.PTP1B inhibition suggests a therapeutic strategy for Rett syndromeLovastatin fails to improve motor performance and survival in methyl-CpG-binding protein2-null miceJointly reduced inhibition and excitation underlies circuit-wide changes in cortical processing in Rett syndrome.Lack of β2-AR Increases Anxiety-Like Behaviors and Rewarding Properties of Cocaine.MeCP2-regulated miRNAs control early human neurogenesis through differential effects on ERK and AKT signaling.Neurotrophic Factors in Mouse Models of Autism Spectrum Disorder: Focus on BDNF and IGF-1.MicroRNAs in neural development: from master regulators to fine-tuners.Effects of spinal non-viral interleukin-10 gene therapy formulated with d-mannose in neuropathic interleukin-10 deficient mice: Behavioral characterization, mRNA and protein analysis in pain relevant tissues.Persistent Expression of Serotonin Receptor 5b Alters Breathing Behavior in Male MeCP2 Knockout Mice.Common Defects of Spine Dynamics and Circuit Function in Neurodevelopmental Disorders: A Systematic Review of Findings From in Vivo Optical Imaging of Mouse Models.
P2860
Q26750525-07903EDB-616A-4AFA-A6A2-D7B8B8538679Q26768284-57402FCF-A491-4FC5-9CC1-8B2A36B90A5BQ26782594-E00D3F13-0BC7-4B9E-88A1-9B6A319AC7E1Q27304440-2BE7908A-B2E2-410F-94E4-E149E9999661Q28069757-C76851FB-414C-4A8B-8A35-4FF27781FE1CQ30355025-748A81F4-12CF-45F5-93FA-1DA9AF15E2B5Q33850875-B83B9140-2EA9-4DB5-8557-DEFEBB9510EBQ33919627-832BE431-2EEE-4702-98C4-19C842CF4CABQ34936657-102E75CA-6BB9-4852-9C5C-BD1299209313Q35303623-2B1E1685-A587-4A72-86EC-A8B9478660D4Q36040491-0DDB8699-95D3-4CD0-9F46-AF88A7FCC29BQ37462636-58E83592-DEE4-4B3B-9A2B-36673B5EC0B1Q37469694-3B5A7476-16B1-4CBB-9DA7-F4F699C8A0D9Q37695174-9A73E1AB-5A13-4C6C-85C6-1DEBE8D8E662Q38821957-5B784D99-A3FB-472F-98DB-4BA520006214Q39334489-A279B51F-55A0-44A3-A0F0-43B3F866DB09Q39414160-7DA5A671-2309-4ACE-A8F9-56CDB77B8EB2Q45874115-AA0FCBD6-7D39-493F-B110-913FA44CBE0CQ52363906-726A4B06-A87C-4467-A2B1-9A4221362295Q55474439-DAD23F77-09C8-449D-8A8E-CF4B57D54C40
P2860
β2-Adrenergic receptor agonist ameliorates phenotypes and corrects microRNA-mediated IGF1 deficits in a mouse model of Rett syndrome
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
β2-Adrenergic receptor agonist ...... a mouse model of Rett syndrome
@ast
β2-Adrenergic receptor agonist ...... a mouse model of Rett syndrome
@en
type
label
β2-Adrenergic receptor agonist ...... a mouse model of Rett syndrome
@ast
β2-Adrenergic receptor agonist ...... a mouse model of Rett syndrome
@en
prefLabel
β2-Adrenergic receptor agonist ...... a mouse model of Rett syndrome
@ast
β2-Adrenergic receptor agonist ...... a mouse model of Rett syndrome
@en
P2093
P2860
P356
P1476
β2-Adrenergic receptor agonist ...... a mouse model of Rett syndrome
@en
P2093
Benjamin Crawford
Jitendra Sharma
Jonathan Woodson
Mriganka Sur
Nikolaos Mellios
Rodrigo I Garcia
Stephen J Haggarty
Steven D Sheridan
P2860
P304
P356
10.1073/PNAS.1309426111
P407
P577
2014-06-23T00:00:00Z